Locations

MALVERN

Private financing in MALVERN, aggregated from public sources.

$1.1B
Capital raised
43
Companies
143
Rounds
2009
First on record
2026-03-16
Latest round

Cooling MALVERN drew $4.7M over the last 12 months, down 85% versus the prior 12 ($31.2M). Of 42 companies rankable against same-niche peers, 17% model over-valued and 38% under-valued.

Capital flow over time

Quarterly capital raised in MALVERN.

2009-Q1 · $6.0M2009-Q12009-Q2 · $915K2009-Q3 · $37.2M2009-Q4 · $2.8M2010-Q1 · $16.2M2010-Q2 · $500K2010-Q3 · $20.1M2010-Q32010-Q4 · $3.3M2011-Q1 · $11.3M2011-Q2 · $70.3M2011-Q3 · $8.2M2011-Q4 · $10.5M2012-Q1 · $21.8M2012-Q12012-Q2 · $11.5M2012-Q3 · $43.2M2012-Q4 · $32.4M2013-Q1 · $3.8M2013-Q3 · $11.0M2013-Q4 · $15.3M2013-Q42014-Q1 · $5.0M2014-Q2 · $500K2014-Q3 · $7.5M2014-Q4 · $88.0M2015-Q1 · $2.0M2015-Q2 · $52.8M2015-Q22015-Q3 · $16.0M2015-Q4 · $37.1M2016-Q1 · $14.0M2016-Q2 · $680K2016-Q3 · $30.0M2016-Q4 · $21.0M2016-Q42017-Q1 · $9.4M2017-Q2 · $22.5M2017-Q3 · $27.1M2017-Q4 · $39.4M2018-Q1 · $39.5M2018-Q2 · $1.5M2018-Q22018-Q3 · $70.2M2018-Q4 · $8.3M2019-Q2 · $43.6M2019-Q4 · $130K2020-Q1 · $3.3M2020-Q2 · $14.4M2020-Q22020-Q3 · $1.5M2020-Q4 · $710K2021-Q2 · $2.4M2021-Q3 · $4.8M2021-Q4 · $5.5M2022-Q1 · $36.7M2022-Q12022-Q2 · $3.5M2022-Q3 · $69.9M2022-Q4 · $3.2M2023-Q1 · $48.0M2023-Q3 · $5.4M2023-Q4 · $2.1M2023-Q42024-Q1 · $1.4M2024-Q3 · $16.1M2024-Q4 · $9.9M2025-Q1 · $3.0M2025-Q2 · $2.3M2025-Q3 · $2.4M2025-Q32025-Q4 · $1.5M2026-Q1 · $800K
Sector mix
SectorCompaniesRoundsCapital
Pharmaceuticals932$400.0M
Biotechnology738$283.6M
Other Health Care626$219.6M
Other Technology817$119.7M
Software / Tech13$35.5M
Healthtech38$20.8M
Other25$11.5M
Medical Devices15$4.9M
Top-funded companies
CompanySectorRaisedModeled value
Zonoff, Inc.Other Technology$35.6M$969.6M
Savana, Inc.Other Technology$54.1M$771.5M
Promedior IncPharmaceuticals$46.3M$739.9M
Encore Dermatology, Inc.Other Health Care$89.6M$729.9M
Usa Technologies IncSoftware / Tech$35.5M$603.3M
Ocugen, Inc.Biotechnology$145.6M$566.9M
Recro Pharma, Inc.Pharmaceuticals$23.8M$544.1M
TELA Bio, Inc.Biotechnology$104.8M$435.1M
Venatorx Pharmaceuticals, Inc.Pharmaceuticals$124.3M$420.5M
Neuronetics, Inc.Other Health Care$118.7M$332.3M
Yaupon Therapeutics IncPharmaceuticals$21.6M$256.8M
Tetralogic Pharmaceuticals CorpPharmaceuticals$27.9M$154.9M
Ascenta Therapeutics, Inc.Pharmaceuticals$1.8M$68.5M
Aevumed Inc.Biotechnology$5.1M$58.9M
Benten BioServices, Inc.Biotechnology$9.4M$58.4M
Y-Prime, Inc.Other Technology$11.6M$57.3M
Oncopia Therapeutics, LLCBiotechnology$8.4M$54.2M
Excision Medical, Inc.Healthtech$18.2M$50.3M
Shifa Biomedical CorpBiotechnology$1.8M$48.3M
Rajant CorpTelecommunications$2.0M$43.1M
Other locations

Browse all locations or the full company rankings.

Frequently asked
How much venture funding have companies in MALVERN raised?
Companies based in MALVERN have raised approximately $1.1B across 143 recorded financing rounds among 43 companies, aggregated from public sources.
Is startup funding in MALVERN growing?
MALVERN funding is currently cooling: capital raised over the last 12 months was down 85% versus the prior 12 months.
What sectors are most active in MALVERN?
The most active sectors in MALVERN by recorded financing are Pharmaceuticals, Biotechnology, Other Health Care, Other Technology. See the sector mix table for company and round counts.
Which are the most-funded companies in MALVERN?
The most-funded MALVERN companies in our coverage include Zonoff, Inc., Savana, Inc., Promedior Inc, Encore Dermatology, Inc., Usa Technologies Inc. See the ranked table for disclosed capital and modeled valuations.